跳至主要内容
临床试验/IRCT201201247202N2
IRCT201201247202N2已完成未知

Comparing the effects of Celecoxib with placebo on inflammatory factors and cognitive impairment in mood disorder patients undergoing electroconvulsive therapy (ECT)

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • Inclusion Criteria: diagnosis of mood disorder according to DSM IV TR criteria by a psychiatrist. Exclusion Cirteria: Patients with Hypersensetivity to celecoxib or other NSAIDs, Patients with rheumatologic disease, Organic Brain Syndrome, Severe Medical Conditions (cardiovascular disorders, hepatic, renal, respiratory, gasterointestinal), diabetes, patients undegoing treatment with of other NSAIDs or corticosteroides, receiving ECT in the past 2 months, hearing or talking problem and pregnanant patients were excluded.

排除标准

  • 未提供

研究者

相似试验

evaluation of adding celecoxib to treatment of mood... | 临床试验